Immunology 4 - lectures 13-15 Flashcards
(36 cards)
What does autologous mean?
from self
What does allogeneic mean?
from a genetically different individual of same species.
What does xenogeneic mean?
from a different species
What does syngeneic mean?
from a genetically identical individual (identical twin)
What is an immune correlate of protection?
immune response to a vaccine closely associated with protection against infection or disease.
What is a neutralizing antibody?
antibody that binds to a virus to prevent attachment or viral replication in a cell.
How are neutralizing antibodies maintained?
1) circulating antibodies
2) long-lived plasma cells (that go primarily to the bone marrow)
3) memory B cells.
What are the three types of memory T cells and how are they distinguished?
1) Centra-memory T cell. Expresses lymph node homing receptor.
2) Effector-memory T cell. Travel all over (blood and tissue) do not express the homing receptor for the lymph nodes.
3) Tissue-resident memory. Don’t circulate, adopt features of resident memory cells.
How are memory cells able to be activated much more quickly than Naive T cells?
Memory T cells do not require costimulation, so can be activated by any APC (DCs, B cells, endothelial cells, macrophages). Produce cytokines more quickly.
How do you attenuate a virus?
Pass the virus through cells of another species; virus mutates to spread in that species, but when doesn’t grow as well in human cells, can be introduced to generate antibodies.
What are the four major considerations for vaccine design?
1) nature of pathogen (bacteria, virus, etc.)
2) mechanism of clearance (antibody vs. T cell)
3) Tissue sight of infection and pathogenesis.
4) safety - protection vs. immunopathology.
What are the major surface structures of influenza targeted by vaccines and what is their function?
1) hemaglutinin (HA) - binds sialyc acid to get in the cell.
2) neuraminidase (NA) - important to assemble inside the cell.
Both proteins have highly conserved and highly variable regions.
How does one treat RSV?
Give palivizumab - monoclonal anti-F protein Ab. Vaccine against RSV in the 1960s caused too strong an immune response.
What are the four types of allograft rejection, when do they occur (temporal relative to transplant date), and what mediates their occurrence?
1) hyper acute rejection: most rapid rejection, occurs due to antibodies already being present against HLA or blood type, antibodies attach to graft, complement cascade, immediate rejection.
2) acute vascular: same mechanism as 1) but initial level of antibodies is low, but quick activation of B cells, more antibodies, similar rapid complement cascade and rejection.
3) cellular: largely T-cell mediated, though some innate contribution due to DAMPs during the transplant process. Due to HLA mismatch.
4) chronic
How do anti-HLA antibodies develop?
pregnancy, blood transfusion (with some leukocytes getting through), previous transplants, natural antibodies against xenografts.
What is difference between direct and indirect allorecognition?
in direct recognition, donor DCs are acting as the APCs, while in indirect recognition, the host DCs act as the APCs.
What are the three major types of immunosuppression typically used?
1) corticosteroids.
2) cytotoxic agents
3) calcinurin inhibitors.
What do calcinurin inhibitors do to T cells?
Reduce IL-2 expression (no T cell proliferation) and suppress exocytosis of cytotoxic granules.
What tissue is primarily affected in graft-versus-host disease?
epithelial tissues - skin, intestinal system, liver.
What is erysipelas?
Common post-surgical complication characterized by fiery red skin, fever/chills, malaise. Due to Strep pyogenes, typically self-limited and rarely fatal.
What types of cells to chemotherapy agents target?
proliferating cells, including gametes, hair follicles, hematopoietic and GI cells.
What are ‘differentiation antigens?’ Provide some examples.
antigens produced in a tissue-specific manner.
CD20 for B cells
Tyrosinase for melanocytes
Prostatic acid phosphatase
What medication is used as immunotherapy against B-cell lymphomas and what is the target for the medication?
Ritaximab - targets CD20 proteins found on B-cell surface (but not plasma cells, so immune damage is acceptable).
Where are the following proteins expressed, and how must immunotherapeutic agents target them?
1) CD20
2) tyrosinase
3) prostatic acid phophatase
1) cell surface
2) cytoplasm
3) cytoplasm